Novartis Plans OTC Market Assault

Swiss drugmaker Novartis has launched its consumer healthcare division in Japan and it is planning to become a top 10 player within the next five years. Given the company's diversified portfolio of products for prevalent conditions coupled with its increasing focus on the Japanese market, BMI is fairly confident that Novartis will achieve its aim of penetrating the over-the-counter (OTC)

To read the full article, please choose one of the following options: